微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 73.86% | 1.54% | -1.94% | 27/159 | 50.44% | 迪哲医药 | 99.22% | 行业排名> |
| 2026-06-30 | 75.32% | 6.69% | -1.52% | 25/159 | 48.66% | 海创药业 | 97.34% | 行业排名> |
| 2026-03-31 | 76.48% | 3.15% | 7.12% | 26/159 | 50.28% | 海创药业 | 99.82% | 行业排名> |
| 2025-12-31 | 71.4% | 0.57% | -1.84% | 32/159 | 50.37% | 海创药业 | 98.62% | 行业排名> |
| 2025-09-30 | 72.74% | -1.48% | 3.03% | 31/159 | -2.13% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 70.6% | -5.16% | -4.78% | 32/159 | 15.05% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 74.14% | 2% | 4.44% | 25/159 | 31.79% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 70.99% | -0.3% | -3.84% | 31/159 | 51.61% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 73.83% | 2% | -0.82% | 25/159 | 22.43% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 74.44% | 9.43% | 4.54% | 26/159 | 32.96% | 百利天恒 | 97.99% | 行业排名> |
| 2023-12-31 | 71.21% | -6.71% | 4.68% | 32/159 | 51.31% | 百利天恒 | 98.92% | 行业排名> |
| 2023-06-30 | 68.02% | -7.68% | -10.88% | 39/159 | 38.22% | 迈威生物 | 98.93% | 行业排名> |
| 2022-12-31 | 76.33% | 7.38% | 3.59% | 29/159 | 53.51% | 迈威生物 | 99.59% | 行业排名> |
| 2022-06-30 | 73.68% | 2% | 3.65% | 36/159 | 20.91% | 迈威生物 | 99.8% | 行业排名> |
| 2021-12-31 | 71.08% | 1.68% | 1.68% | 41/159 | 54.9% | 迈威生物 | 99.46% | 行业排名> |
| 2020-12-31 | 69.91% | 2% | 2% | 38/159 | -147.51% | 迈威生物 | 99.75% | 行业排名> |